| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K71935468 | CTRPv2 | pan-cancer | AAC | 0.041 | 0.3 |
| mRNA | BRD9876:MK-1775 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.12 | 0.3 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.3 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -0.055 | 0.3 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.039 | 0.3 |
| mRNA | dinaciclib | CTRPv2 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.081 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.051 | 0.3 |
| mRNA | nelarabine | CTRPv2 | pan-cancer | AAC | -0.04 | 0.3 |